Show Archives

Symptom-less

Kevin O’Neill calls in for hour one to discuss the latest on COVID-19 before breaking down the difficulty in turning around failing organizations based on his own personal experience. Russell Rhoads calls in for hour two to discuss the pending Coronavirus relief bill awaiting signature.

Listen to this show


Black Swan

Chief and Executive Producer, Matt Weber, lead off the show, raising vitally important concerns on the current situation. Chicago attorney, Brendan Cournane, joins the discussion of the ongoing crisis. Joel Elconin of Benzinga, calls in and gives his opinion on the market affected by the virus. Jeff Joseph, Editorial Director & Publisher at Luckbox Magazine, calls in for hour two addressing the global issue and provides the latest updates on the coronavirus. Don’t forget, Stocks & Jocks listeners receive a FREE digital subscription at luckboxmagazine.com/jocks. Sign up today!

Listen to this show


Where’s the Data?

Options guru and veteran floor trader, Frank Fahey, leads off wondering why we don’t seem to have reliable public data on COVID-19. John Flannigan continues the Coronavirus conversation. David Andalman of PTI Securities & Futures closes the show previewing where he thinks the markets are headed.

Listen to this show


Testing Our Patience

Kevin O’Neill calls in to discus the news of the day including a Supreme Court outcome and a scandal involving (at least) five U.S. Senators dumping stock ahead of the market crash. Karl Denninger of Market Ticker joins the show in hour two for a lively discussion on the impact of this virus and where to go from here.

Listen to this show


No Vaccine, No Bottom

Lou Michels joins us for hour one talking COVID-19, his personal experience with Dr. Anthony Fauci, and the latest on the United States Women’s National Team’s lawsuit against U.S. Soccer. Fari Hamzei of Hamzei Analytics says without a vaccine there’s no ‘bottom’ in the market. David Andalman of PTI Securities & Futures believes our government’s reaction to the outbreak doesn’t align with the data.

Listen to this show